Intuitive Surgical upgraded to Outperform, price target $700 at JMP Securities JMP Securities upgraded Intuitive Surgical two notches to Outperform from Underperform given the da Vinci system Xi opportunity. The firm raised 2015 EPS estimate to $19.04 from $16.47 and revenue estimate to $2.7B from $2.4B and its price target to $700 from $320.
Intuitive Surgical initiated with an Overweight, $575 target at Barclays Barclays analyst Matthew Taylor started shares of Intuitive Surgical with an Overweight rating and $575 price target. Taylor thinks surgery share will continue to shift to robotic and believes demand for Intuitive's da Vinci among general surgeons is very high. The stock closed yesterday down $4.17 to $492.45.